CVApr 11, 2023Code
Regression-based Deep-Learning predicts molecular biomarkers from pathology slidesOmar S. M. El Nahhas, Chiara M. L. Loeffler, Zunamys I. Carrero et al.
Deep Learning (DL) can predict biomarkers from cancer histopathology. Several clinically approved applications use this technology. Most approaches, however, predict categorical labels, whereas biomarkers are often continuous measurements. We hypothesized that regression-based DL outperforms classification-based DL. Therefore, we developed and evaluated a new self-supervised attention-based weakly supervised regression method that predicts continuous biomarkers directly from images in 11,671 patients across nine cancer types. We tested our method for multiple clinically and biologically relevant biomarkers: homologous repair deficiency (HRD) score, a clinically used pan-cancer biomarker, as well as markers of key biological processes in the tumor microenvironment. Using regression significantly enhances the accuracy of biomarker prediction, while also improving the interpretability of the results over classification. In a large cohort of colorectal cancer patients, regression-based prediction scores provide a higher prognostic value than classification-based scores. Our open-source regression approach offers a promising alternative for continuous biomarker analysis in computational pathology.
CVNov 20, 2023
Benchmarking Pathology Feature Extractors for Whole Slide Image ClassificationGeorg Wölflein, Dyke Ferber, Asier R. Meneghetti et al.
Weakly supervised whole slide image classification is a key task in computational pathology, which involves predicting a slide-level label from a set of image patches constituting the slide. Constructing models to solve this task involves multiple design choices, often made without robust empirical or conclusive theoretical justification. To address this, we conduct a comprehensive benchmarking of feature extractors to answer three critical questions: 1) Is stain normalisation still a necessary preprocessing step? 2) Which feature extractors are best for downstream slide-level classification? 3) How does magnification affect downstream performance? Our study constitutes the most comprehensive evaluation of publicly available pathology feature extractors to date, involving more than 10,000 training runs across 14 feature extractors, 9 tasks, 5 datasets, 3 downstream architectures, 2 levels of magnification, and various preprocessing setups. Our findings challenge existing assumptions: 1) We observe empirically, and by analysing the latent space, that skipping stain normalisation and image augmentations does not degrade performance, while significantly reducing memory and computational demands. 2) We develop a novel evaluation metric to compare relative downstream performance, and show that the choice of feature extractor is the most consequential factor for downstream performance. 3) We find that lower-magnification slides are sufficient for accurate slide-level classification. Contrary to previous patch-level benchmarking studies, our approach emphasises clinical relevance by focusing on slide-level biomarker prediction tasks in a weakly supervised setting with external validation cohorts. Our findings stand to streamline digital pathology workflows by minimising preprocessing needs and informing the selection of feature extractors.
CVJun 30, 2025
Three-dimensional end-to-end deep learning for brain MRI analysisRadhika Juglan, Marta Ligero, Zunamys I. Carrero et al.
Deep learning (DL) methods are increasingly outperforming classical approaches in brain imaging, yet their generalizability across diverse imaging cohorts remains inadequately assessed. As age and sex are key neurobiological markers in clinical neuroscience, influencing brain structure and disease risk, this study evaluates three of the existing three-dimensional architectures, namely Simple Fully Connected Network (SFCN), DenseNet, and Shifted Window (Swin) Transformers, for age and sex prediction using T1-weighted MRI from four independent cohorts: UK Biobank (UKB, n=47,390), Dallas Lifespan Brain Study (DLBS, n=132), Parkinson's Progression Markers Initiative (PPMI, n=108 healthy controls), and Information eXtraction from Images (IXI, n=319). We found that SFCN consistently outperformed more complex architectures with AUC of 1.00 [1.00-1.00] in UKB (internal test set) and 0.85-0.91 in external test sets for sex classification. For the age prediction task, SFCN demonstrated a mean absolute error (MAE) of 2.66 (r=0.89) in UKB and 4.98-5.81 (r=0.55-0.70) across external datasets. Pairwise DeLong and Wilcoxon signed-rank tests with Bonferroni corrections confirmed SFCN's superiority over Swin Transformer across most cohorts (p<0.017, for three comparisons). Explainability analysis further demonstrates the regional consistency of model attention across cohorts and specific to each task. Our findings reveal that simpler convolutional networks outperform the denser and more complex attention-based DL architectures in brain image analysis by demonstrating better generalizability across different datasets.